FDA FAQs
      Back to home
      1. TIP FAQs
      2. TIP and Other Treatments
      3. FDA FAQs

      What is Palforzia?

      Palforzia is a peanut oral immunotherapy (OIT) product approved by the FDA in January 2020. It is a peanut allergen powder that helps reduce the risk and severity of allergic reactions to peanuts, including anaphylaxis, in children ages 4 to 17. Its benefits are limited to peanut allergies. Palforzia is a medication that must be taken daily to maintain the treatment effect.